Table 3.
Logistic regression model* of the surgical and oncologic outcomes in the study population.
| Predictor |
Postoperative morbidity |
|
|---|---|---|
| Adjusted RR (95% CI) | P value | |
| Cancer stage | ||
| 1A | Referent | |
| 1B | 1.10 (0.23–5.21) | 0.904 |
| EBL | ||
| < Median (90 mL) | Referent | |
| ≥ Median | 3.02 (0.64–14.32) | 0.163 |
| Hysterectomy approach | ||
| Open | Referent | |
| Minimally invasive | 0.27 (0.05–1.13) | 0.071 |
| CA-CCI score | ||
| < Median (7) | Referent | |
| ≥ Median | 9.06 (1.78–46.25) | 0.008 |
| Postoperative infection | ||
| Adjusted RR (95% CI) | P value | |
| Cancer stage | ||
| 1A | Referent | |
| 1B | 0.80 (0.15–4.29) | 0.790 |
| EBL | ||
| < Median (90 mL) | Referent | |
| ≥ Median | 2.27 (0.42–12.37) | 0.342 |
| Hysterectomy approach | ||
| Open | Referent | |
| Minimally invasive | 0.14 (0.02–0.84) | 0.032 |
| CA-CCI score | ||
| < Median (7) | Referent | |
| ≥ Median | 8.66 (1.53–48.91) | 0.015 |
| Three-year survival | ||
| Adjusted RR (95% CI) | P value | |
| Cancer stage | ||
| 1A | Referent | |
| 1B | 2.97 (0.16–55.10) | 0.465 |
| EBL | ||
| < Median (90 mL) | Referent | |
| ≥ Median | 0.055 (0.004–6.41) | 0.167 |
| CA-CCI score | ||
| < 90th percentile (8) | Referent | |
| ≥ 90th percentile | 0.06 (0.004–0.87) | 0.039 |
*Model also adjusted for histologic grade and lymph node dissection status. EBL, estimated blood loss; CA-CCI, combined age-Charlson comorbidity index; RR, risk ratio; CI, confidence interval.